Y. Niinaka et al., EXPRESSION AND SECRETION OF NEUROLEUKIN PHOSPHOHEXOSE ISOMERASE MATURATION FACTOR AS AUTOCRINE MOTILITY FACTOR BY TUMOR-CELLS, Cancer research, 58(12), 1998, pp. 2667-2674
The results obtained from fragmented protein microsequencing have sugg
ested that autocrine motility factor (AMF), a tumor-secreted M-r 55,00
0 cytokine that regulates cell motility in vitro as well as invasion a
nd metastasis in vivo, is the neuroleukin (NLK)/phosphohexose isomeras
e (PHI)/maturation factor (MF) polypeptide. Here, we cloned, sequenced
, and studied the expression, secretion, and distribution of AMF/NLK/P
HI/MF in neoplastic and their normal counterpart cells. Although both
normal and neoplastic cells express the gene product, overexpression a
ssociated with selective secretion of the protein was observed only in
tumor cells. The cDNA sequences of AMF/NLK/PHI/MF found in both human
cancer and normal cells were found to be identical, suggesting that i
ts secretion by neoplastic cells is independent of mutation or alterna
tive splicing. Immunohistochemical visualization has depicted AMF/NLK/
PHI/MF to be localized into tubular-like vesicles, diffusely distribut
ed throughout the cytoplasm and not colocalized with any particular cy
toskeletal network. Confocal microscopic imaging had shown a partial c
olocalization between AMF and its receptor (M-r 78,000 glycoprotein),
especially on the malignant cell surface periphery. The results sugges
t that extracellular AMF activity may be a result of the product of in
tracellular cleavage of a precursor polypeptide, which is overexpresse
d and selectively secreted through a nonclassical secretory mechanism
by neoplastic cells.